Platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane derivatives as carrier ligands and 3-hydroxycyclobutane-1,1-dicarboxylate as a leaving group: potent cytotoxicity and DNA binding ability.

[1]  S. Gou,et al.  Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligands. , 2012, European journal of medicinal chemistry.

[2]  S. Gou,et al.  Novel hydrophilic cis-bis(cyclopentylamine)platinum(II) complexes: Synthesis, characterization, antitumor activity and interaction with DNA , 2012 .

[3]  S. Gou,et al.  Antitumor platinum(II) complexes of N-monoalkyl-1R, 2R-diaminocyclohexane derivatives with alkyl groups as hindrance. , 2012, Journal of inorganic biochemistry.

[4]  S. Gou,et al.  Synthesis, in vitro Cytotoxicity, and Interaction with DNA of Platinum(II) Complexes with N‐Monocycloalkyl Derivatives of 1R,2R‐Diaminocyclohexane as Carrier Ligands , 2012, ChemMedChem.

[5]  W. Berger,et al.  {(1R,2R,4R)-4-methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): a novel enantiomerically pure oxaliplatin derivative showing improved anticancer activity in vivo. , 2010, Journal of medicinal chemistry.

[6]  L. Lou,et al.  Synthesis and anticancer activity of lipophilic platinum(II) complexes of 3,5-diisopropylsalicylate. , 2008, European journal of medicinal chemistry.

[7]  Kai Cui,et al.  In vitro cytotoxicity study on platinum (II) complexes with epoxysuccinates as leaving groups. , 2007, Bioorganic & medicinal chemistry letters.

[8]  H. Görls,et al.  Synthesis and Characterization of [(1R,2R)‐trans‐Diaminocyclohexane]platinum(II) Coordinated to Sulfur and Selenium Amino Acids , 2006 .

[9]  S. Pang,et al.  Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane. , 2006, Bioorganic & medicinal chemistry letters.

[10]  M. Galanski,et al.  Synthesis and structure-activity relationships of mono- and dialkyl-substituted oxaliplatin derivatives. , 2005, European journal of medicinal chemistry.

[11]  Dong Wang,et al.  Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.

[12]  T. Hambley.  The influence of structure on the activity and toxicity of Pt anti-cancer drugs , 1997 .

[13]  J. Barton,et al.  Binding of cis- and trans-dichlorodiammineplatinum(II) to DNA: evidence for unwinding and shortening of the double helix. , 1979, Science.